Literature DB >> 9560870

Elevated levels of psychophysiological arousal and cortisol in patients with somatization syndrome.

W Rief1, R Shaw, M M Fichter.   

Abstract

OBJECTIVE: This study investigates psychological and psychobiological processes in patients with somatization syndrome.
METHOD: We compared physiological measures (heart rate, finger pulse volume, electrodermal activity, electromyography), cortisol levels, and subjective well-being during rest and during a mental stress task as well as selective attention and memory for illness-related words in 58 patients with somatization syndrome and 21 healthy controls.
RESULTS: The somatization group had higher morning salivary cortisol concentrations, higher heart rates, and lower levels of finger pulse volume. During the mental stress task, patients with somatization syndrome felt more distressed and had higher heart rates, whereas controls showed habituation to the experimental situation. We were unable to demonstrate an attention or memory bias specific for somatization.
CONCLUSIONS: The results point to several psychological, psychophysiological, and psychobiological mechanisms that might be involved in the maintenance of somatization syndrome. These results are discussed from a cognitive-psychobiological perspective.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9560870     DOI: 10.1097/00006842-199803000-00016

Source DB:  PubMed          Journal:  Psychosom Med        ISSN: 0033-3174            Impact factor:   4.312


  10 in total

1.  Stimulation of the cholinergic neurotransmissions enhances the efficacy of vestibular rehabilitation.

Authors:  D Monzani; E Genovese; A Marrara; L Presutti; C Gherpelli; P Panzetti; M Forghieri
Journal:  Acta Otorhinolaryngol Ital       Date:  2010-02       Impact factor: 2.124

2.  Depression and anxiety correlate differently with salivary free cortisol in the morning in patients with functional somatic syndrome.

Authors:  Hiromi Mutsuura; Kenji Kanbara; Mikihiko Fukunaga; Kazumi Yamamoto; Ikumi Ban; Kana Kitamura; Yoshihide Nakai
Journal:  Appl Psychophysiol Biofeedback       Date:  2009-08-07

3.  Exploring psychophysiological markers of vulnerability to somatic illnesses in females.

Authors:  Alison E Hipwell; Kate Keenan; Anna Marsland
Journal:  J Pediatr Psychol       Date:  2009-03-13

4.  Why reassurance fails in patients with unexplained symptoms--an experimental investigation of remembered probabilities.

Authors:  Winfried Rief; Andrea Maren Heitmüller; Katja Reisberg; Heinz Rüddel
Journal:  PLoS Med       Date:  2006-08       Impact factor: 11.069

Review 5.  Interoception and stress.

Authors:  André Schulz; Claus Vögele
Journal:  Front Psychol       Date:  2015-07-20

6.  The Association between Baseline Subjective Anxiety Rating and Changes in Cardiac Autonomic Nervous Activity in Response to Tryptophan Depletion in Healthy Volunteers.

Authors:  Chih Yin Hsiao; Hsin Chun Tsai; Mei Hung Chi; Kao Chin Chen; Po See Chen; I Hui Lee; Tzung Lieh Yeh; Yen Kuang Yang
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

Review 7.  Emotional processing in functional neurological disorder: a review, biopsychosocial model and research agenda.

Authors:  David L Perez; Timothy R Nicholson; Susannah Pick; Laura H Goldstein
Journal:  J Neurol Neurosurg Psychiatry       Date:  2018-11-19       Impact factor: 10.154

Review 8.  The critical role of psychosomatics in promoting a new perspective upon health and disease.

Authors:  Dorin Dragoş; Maria Daniela Tănăsescu
Journal:  J Med Life       Date:  2009 Oct-Dec

Review 9.  Medically unexplained physical symptoms in medical practice: a psychiatric perspective.

Authors:  Javier I Escobar; Constanza Hoyos-Nervi; Michael Gara
Journal:  Environ Health Perspect       Date:  2002-08       Impact factor: 9.031

10.  Longer-term increased cortisol levels in young people with mental health problems.

Authors:  Kareen Heinze; Ashleigh Lin; Renate L E P Reniers; Stephen J Wood
Journal:  Psychiatry Res       Date:  2015-12-18       Impact factor: 3.222

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.